Advanced paternal age and risk of schizophrenia in offspring review of epidemiological findings and potential mechanisms
Currently, cagrilintide remains investigational and available only as a research chemical while awaiting FDA approval expected 2025-2026
Goktas SB, Manukyan M, Selimen D
Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al
Here is where the public conversation goes off the rails: weight regain after stopping treatment is being framed as evidence that treatment is not worth it, or that patients are stuck on it for life, as if that is a moral failing or some unique downside in obesity care
When my trainer mentioned Retatrutide as an option to pair with my existing TRT protocol, I was skeptical